The withdrawal of drugs for commercial reasons: the incomplete story of tositumomab

MeSH terms

• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / adverse effects*
• Antibodies, Monoclonal, Murine-Derived / therapeutic use
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / adverse effects*
• Clinical Trials, Phase IV as Topic
• Commerce
• Drug Approval
• Drug Industry / economics*
• Drug Prescriptions / statistics & numerical data*
• Humans
• Lymphoma, Follicular / drug therapy*
• Lymphoma, Follicular / mortality
• Recurrence
• Rituximab
• Survival Analysis
• Treatment Failure
• Treatment Outcome
• United States
• United States Food and Drug Administration